No evidence for fibroblast growth factor receptor 3 (FGFR-3) R248C/S249C mutations in human prostate cancer

被引：0
|
作者：
Naimi, B
Latil, A
Berthon, P
Cussenot, O
机构：
[1] Univ Paris 07, CeRePP, EA 3104, F-91000 Evry, France
[2] Genopole, UroGene, F-91000 Evry, France
[3] Inst Anat St Peres, Paris, France
[4] Inst Univ France, Paris, France
来源：
INTERNATIONAL JOURNAL OF CANCER | 2000年 / 87卷 / 03期
关键词：
D O I：
10.1002/1097-0215(20000801)87:3<455::AID-IJC23>3.3.CO;2-H
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：455 / 456
页数：2
相关论文
共 50 条
  • [21] Identification of a novel S249C FGFR3 mutation in a keratinocytic epidermal naevus syndrome
    Ousager, L. B.
    Bygum, A.
    Hafner, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (01) : 202 - 204
  • [22] Fibroblast growth factor receptor (FGFR)-3 as a suitable target in bladder cancer
    Gust, Kilian M.
    McConkey, David J.
    Hegarty, Paul K.
    Bondaruk, Jolanta E.
    Czerniak, Bogdan A.
    Dinney, Colin P.
    Black, Peter C.
    CANCER RESEARCH, 2011, 71
  • [23] APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer
    Shi, Ming-Jun
    Meng, Xiang-Yu
    Lamy, Philippe
    Banday, A. Rouf
    Yang, Jie
    Moreno-Vega, Aura
    Chen, Chun-Long
    Dyrskjot, Lars
    Bernard-Pierrot, Isabelle
    Prokunina-Olsson, Ludmila
    Radvanyi, Francois
    EUROPEAN UROLOGY, 2019, 76 (01) : 9 - 13
  • [24] Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
    Pouessel, D.
    Neuzillet, Y.
    Mertens, L. S.
    van der Heijden, M. S.
    de Jong, J.
    Sanders, J.
    Peters, D.
    Leroy, K.
    Manceau, A.
    Maille, P.
    Soyeux, P.
    Moktefi, A.
    Semprez, F.
    Vordos, D.
    de la Taille, A.
    Hurst, C. D.
    Tomlinson, D. C.
    Harnden, P.
    Bostrom, P. J.
    Mirtti, T.
    Horenblas, S.
    Loriot, Y.
    Houede, N.
    Chevreau, C.
    Beuzeboc, P.
    Shariat, S. F.
    Sagalowsky, A. I.
    Ashfaq, R.
    Burger, M.
    Jewett, M. A. S.
    Zlotta, A. R.
    Broeks, A.
    Bapat, B.
    Knowles, M. A.
    Lotan, Y.
    van der Kwast, T. H.
    Culine, S.
    Allory, Y.
    van Rhijn, B. W. G.
    ANNALS OF ONCOLOGY, 2016, 27 (07) : 1311 - 1316
  • [25] Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix
    Rong Wu
    Denise Connolly
    Cora Ngelangel
    F Xavier Bosch
    Nubia Muñoz
    Kathleen R Cho
    Oncogene, 2000, 19 : 5543 - 5546
  • [26] Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix
    Wu, R
    Connolly, D
    Ngelangel, C
    Bosch, FX
    Muñoz, N
    Cho, KR
    ONCOGENE, 2000, 19 (48) : 5543 - 5546
  • [27] βKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c
    Suzuki, Masashi
    Uehara, Yuriko
    Motomura-Matsuzaka, Kaori
    Oki, Junko
    Koyama, Yoshinori
    Kimura, Miho
    Asada, Masahiro
    Komi-Kuramochi, Akiko
    Oka, Syuichi
    Imamura, Toru
    MOLECULAR ENDOCRINOLOGY, 2008, 22 (04) : 1006 - 1014
  • [28] Biglycan is a novel binding partner of fibroblast growth factor receptor 3c (FGFR3c) in the human testis (vol 399, pg 235, 2015)
    Winge, S. B.
    Nielsen, J.
    Jorgensen, A.
    Owczarek, S.
    Ewen, K. A.
    Nielsen, J. E.
    Juul, A.
    Berezin, V.
    Rajpert-De Meyts, E.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2018, 460 (0C) : 258 - 258
  • [29] Somatic and germline mosaicism for a R248C missense mutation in FGFR3, resulting in a skeletal dysplasia distinct from thanatophoric dysplasia
    Hyland, VJ
    Robertson, SP
    Flanagan, S
    Savarirayan, R
    Roscioli, T
    Masel, J
    Hayes, M
    Glass, IA
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 120A (02) : 157 - 168
  • [30] Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism
    Bonaventure, J
    Rousseau, F
    LegeaiMallet, L
    LeMerrer, M
    Munnich, A
    Maroteaux, P
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1996, 63 (01): : 148 - 154
12345